Status:
UNKNOWN
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients qu...
Detailed Description
Participants will be asked to complete a questionnaire about their health prior to treatment, at 1, 3 and 12 months after treatment and then once a year 4 more times.
Eligibility Criteria
Inclusion
- Pathological diagnosis of an adenocarcinoma of the prostate
- 18 years of age or older
- Prior choice of either standard brachytherapy or MRIGPB as primary treatment
Exclusion
- Prior primary therapy (surgery or external beam radiation) for prostate cancer
- Current hormone ablation therapy
Key Trial Info
Start Date :
March 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2011
Estimated Enrollment :
414 Patients enrolled
Trial Details
Trial ID
NCT00681694
Start Date
March 1 2002
End Date
March 1 2011
Last Update
April 28 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Dana-Farber Cancer Institute/Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
3
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215